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Blood-brain barrier (BBB) is a selective and
dynamic structure, formed by endothelial cells, that
allows the selective passage of substances from
blood to CNS and vice versa. During brain develop-
ment, brain capillary endothelial cells (BCECs)
gradually acquire the ability to form a selective bar-
rier, and it is known that astrocytes [1] as well as
neurons [2] play an inductive role in this process.
BCECs are joined together by intercellular tight
junctions (TJs) that are responsible for acquisition
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Abstract
We previously found that RBE4.B brain capillary endothelial cells (BCECs) form a layer with blood-brain barrier
(BBB) properties if co-cultured with neurons for at least one week. As astrocytes are known to modulate BBB func-
tions, we further set a culture system that included RBE4.B BCECs, neurons and astrocytes. In order to test formation
of BBB, we measured the amount of 3H-sucrose able to cross the BCEC layer in this three-cell type model of BBB.
Herein we report that both neurons and astrocytes induce a decrease in the permeability of the BCEC layer to sucrose.
These effects are synergic as if BCECs are cultured with both neurons and astrocytes for 5 days, permeability to
sucrose decreases even more. By Western analysis, we also found that, in addition to the canonical 60 kDa occludin,
anti-occludin antibodies recognize a smaller protein of 48 kDa which accumulates during rat brain development.
Interestingly this latter protein is present at higher amounts in endothelial cells cultured in the presence of both astro-
cytes and neurons, that is in those conditions in which sucrose permeation studies indicate formation of BBB.
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of selective permeability. This latter property is spe-
cific of brain TJs and probably depends on the high-
er density of proteins such as occludin and ZO-1 [3,
4] in brain TJs than in TJs of other tissues. An addi-
tional level of regulation seems to rise from vari-
ability of occludin. Occludin isoforms, deriving
from alternative RNA splicing [5, 6], as well as
alternative occludin promotors [6] have been
indeed described [for recent review, see: 7].
Alterations of BBB structure and function correlate
with neurodegeneration [8] and cancer [9–11]. On
the other hand, the existence of a functional BBB
challenges treatment of neurodegeneration because
drugs have to cross BBB to gain access to brain.
Given the importance of understanding the
molecular mechanisms underlying genesis and
maintenance of BBB, many authors attempted to set
in vitro models based on cocultures of brain cells
[reviewed in: 12]. Most in vitro systems are two-
cell type cocultures, including astrocytes and
BCECs [1, 13, 14] or, sometimes, BCECs and neu-
rons [2, 15].
We previously described a more complete,
three-cell type syngenic in vitro model, built up
with rat BCECs [RBE4.B cells: 16], astrocytes and
neurons [17]. Herein we report that both neurons
and astrocytes induce a decrease in the permeabili-
ty of the BCEC layer to sucrose. These effects are
synergic as BCECs cultured with both cell types
show lower permeability to sucrose respect to cells
cultured with either neurons or astrocytes alone.
By Western analysis, we also identified a protein
of about 48 kDa that is recognized by anti-occludin
antibodies and accumulates during rat brain devel-
opment. This protein is present at higher amounts in
endothelial cells cocultured with both astrocytes
and neurons, where sucrose permeation studies
indicate formation of BBB.
Materials and methods
Animals
Wistar rats (Stefano Morini, San Polo d'Enza, Italy)
were housed in our institutional care facility under
direction of a licensed veterinary. Procedures involving
animals were conducted according to the European
Community Concil Directory 86/609, OJL 358 1, 12
December 1987.
Cell cultures and establishment of the
three-cell type culture system 
RBE4.B immortalized rat brain microvessel endothelial
cells (BCECs) were a kind gift of Dr. F. Roux [16],
under the permission of Neurotech SA (Orsay, France).
Cortical neurons, astrocytes and RBE4.B BCECs were
cultured as previously described [17]. Briefly, neurons
were purified from rat brain cortex at the 16th day of
gestation and cultured at the bottom of laminin-coated
(2.5 μg/cm2) wells, in the serum-free Maat Medium
(MM) [18]. Astrocytes were purified from brain cor-
tices of two-day old rats, as described by Cole and de
Vellis [19], with the modifications reported by Schiera
et al. [17], and cultured in DME:Ham's F12 (2:1), sup-
plemented with 10% heat-inactivated fetal calf serum.
Astrocytes to be used for the three-cell type system
were then progressively adapted to MM, and finally
plated on the outside of fibronectin-coated (2.5 μg/ml)
inserts (translucent, high density type, 23 mm diameter,
0.4 μ pore size, Falcon). After 4 hours, the inserts were
placed into the wells where neurons had been already
cultured for at least two days. RBE4.B BCECs were
plated on collagen I (6 μg/ml) and maintained in
DME:Ham's F12 (2:1), supplemented with 10% fetal
calf serum. Cells were then progressively adapted to
MM and finally plated inside the same inserts, previ-
ously coated with collagen IV (3.5 μg/ml), on which
astrocytes had been plated two days before. As con-
trols, RBE4.B BCECs were also cultured with either
neurons or astrocytes alone and without any other brain
cell type. All control- and three-cell type- cultures were
fed for 3-5 days with daily changes of MM, in the insert
chamber, before running permeability tests or harvest-
ing cells for protein analyses.
Sucrose permeation studies
[3H]Sucrose (Amersham, Cologno Monzese, Italy;
specific activity : 6.00 Ci/mmol) was diluted in MM, at
a final concentration of 0.5 μCi/ml. An aliquot of this
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solution (about 50 μCi of [3H]Sucrose) was then added
to each insert (i.e. the donor compartment). At differ-
ent times (30, 60, 120, 240 and 360 minutes) after
sucrose addition, 100 μl of medium were collected
from both the donor and the acceptor compartment and
counted in a liquid scintillation system by using an
LS6500 Multipurpose scintillation counter (Beckman
Counter TM, USA). [3H] counts/100 μl were used to
calculate total counts in the donor- and acceptor- com-
partment, respectively, as well as the total counts in the
whole system (donor plus acceptor compartment). The
percent of [3H] counts found in the donor compartment
is indicated as "percent of crossing sucrose" through-
out the paper.
Western analyses
Brain cortices from developing or adult rats were
homogenized in homogenization buffer (0.32 M
sucrose; 50 mM sodium phosphate buffer, pH 6.5; 50
mM KCl, 0.5 mM spermine; 0.15 mM spermidine; 2
mM EDTA, and 0.15 mM EGTA), containing the pro-
tease inhibitors aprotinin (2 μg/ml), antipain (2
μg/ml), leupeptin (2 μg/ml), pepstatin A (2 μg/ml),
benzamidine (1.0 mM), and phenylmethylsulfonyl flu-
oride (1.0 mM), all purchased from Sigma. Proteins
(20 μg of total cell extracts) were separated by elec-
trophoresis on denaturing 10% polyacrylamide slab
gels (SDS-PAGE) and immunoblotted as described
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Fig. 1 Schematic drawing of the three-cell type- coculture system. Neurons are cultured at the bottom of the well,
also called acceptor compartment. Astrocytes are cultured on the external surface of the inserts and face neurons in
the acceptor compartment. BCECs are cultured inside the inserts and face the donor compartment. See the main text
for more details.
elsewhere [2], by using rabbit anti-human occludin
antibodies (Santa Cruz, California, USA) directed
against an internal region of human occludin
(aminoacids 132–411).
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Fig. 2 Percent of [3H]Sucrose that crosses a layer of
BCECs cultured for 3 days in serum-free Maat
Medium. BCECs were cultured alone (EC) or in the
presence of astrocytes (ECA), neurons (ECN) or both
cell types (ECAN), for different periods of time (30, 60
and 120 min). Bars indicate the average of at least 3
independent experiments. Standard deviations are indi-
cated. 
Fig. 3 Percent of [3H]Sucrose that crosses a layer of
BCECs cultured for 5 days in serum-free Maat
Medium. BCECs were cultured alone (EC) or in the
presence of astrocytes (ECA), neurons (ECN) or both
cell types (ECAN), for different periods of time (30, 60,
120 and >240 min). Bars indicate the average of at least
3 independent experiments. Standard deviations are
indicated.
Fig. 4 Immunostaining with anti-occludin antibodies
of total proteins from developing rat brain. Protein
extracts (20 μg) were analyzed by Western blot as
described under "Materials and Methods". One of these
analyses is shown in A. Graphic representation of statis-
tical analysis of data from three different experiments is
reported in B (for p48) and C (for p60). 
P, postnatal day of development; A, adult brain
Statistical analyses
As explained above, counts per minute of [3H]Sucrose in
both the acceptor and donor compartments were used to
calculate percent of sucrose that crossed the RBE4.B
BCEC layer. Mean values and standard deviations were
calculated from at least three different experiments. 
Western blots were scanned and planimetries of scans
were used to calculate, by IMAGEJ program, the relative
abundance of occludin; values were normalized with
respect to the total amount of proteins in each lane. Mean
values and standard deviations were calculated from 4 dif-
ferent experiments.
Statistical significance of the differences found in both
sucrose permeability assays and western analyses was
evaluated by Student t test and calculation of the p value.
Results
Sucrose permeation studies
RBE4.B BCECs, astrocytes and neurons were puri-
fied and cultured as described under "Materials and
Methods". The final culture system was built up
with: i) neurons on laminin, at the bottom of wells,
ii) astrocytes, on fibronectin, on the outside of tran-
swell inserts, and iii) RBE4.B BCECs, on collagen
IV, on the inside of the inserts. All the cells were fed
with serum-free Maat Medium. The complete sys-
tem was schematically drawn in Fig. 1.
After either 3 or 5 days of culture, [3H]Sucrose
was added to the donor compartment and its concen-
tration in both the donor- and acceptor- compart-
ments was measured after different periods of time
(30-360 minutes).
We found that RBE.4B BCECs cultured for 3
days with neurons and/or astrocytes (Fig. 2) formed
a better barrier than control cells: the percent of
crossing sucrose was significantly lower (p < 0.05)
in all the cocultures with respect to RBE4.B BCECs
cultured without other brain cells. On the other
hand, no significant difference was noticed that
could depend on which brain cell types (neurons,
astrocytes or both of them) were used in the cocul-
ture system.
When RBE4.B BCECs were cultured with other
brain cells for at least 5 days (Fig. 3), the percent of
crossing sucrose was always much lower than in the
case of BCECs cultured alone: i.e. about one half, if
cocultures included either neurons or astrocytes
(p<0.05) or about one third, if cocultures included
both astrocytes and neurons (p<0.005).
Expression of putative occludin in
developing rat brain and RBE4.B BCECs
cultered alone or with other rat brain cells
As shown in Fig.4, the rabbit anti-human occludin
antibodies (Santa Cruz, California, USA), directed
against an internal region of human occludin
(aminoacids 132-411), recognized as expected a
protein of about 60 kDa (p60, Fig. 4A), the concen-
tration of which increases from birth to postnatal
day 15 (P15) (Fig. 4C). These antibodies also
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Fig. 5 Immunostaining with anti-occludin antibodies
of total proteins from BCECs cultured for 5 days in
serum-free Maat Medium. BCECs were cultured alone
(EC) or in the presence of astrocytes (ECA), neurons
(ECN) or both cell types (ECAN). Two representative
western analyses are shown in panels A and B. Graphic
representations of the statistical analysis of data from
four different experiments are reported in C (for p48)
and D (for p60). E18, cell extract from rat brain at the
18th day of fetal development; A, adult rat brain.
immunostain a protein of about 48 kDa (p48, Fig.
4A) whose concentration increases during develop-
ment even more than that of p60 (Fig. 4B).
Moreover, p48, but not p60 (Fig. 5), is enriched in
RBE4.B BCECs cultured with both astrocytes and
neurons for 5 days, that is in those conditions in
which the BCEC layer shows maximal effieciency
as a barrier to sucrose passage.
Discussion
Many authors attempted to set in vitro models that
make use of cocultures of brain cells [reviewed in:
12]. These in vitro systems are for most two-cell
type cocultures, including astrocytes and BCECs
[1, 13, 14] or, sometimes, BCECs and neurons [2,
15]; as a consequence, these models are too simple
respect to the in vivo situation and are not likely to
reproduce many of the cell-cell interactions that
control BBB formation and maintenance in the
mammalian brain. Moreover, some of these in vitro
systems rely on endothelial cells that do not belong
to the same animal species of the other brain cells
used in the system.
We previously described a three-cell type in
vitro model that includes rat BCECs [RBE4.B
BCECs: 16], astrocytes and neurons [17]. Those
preliminary experiments had shown that, in the
presence of astrocytes, the neuron-induced synthe-
sis and peripheral localization of occludin is preco-
cious (5 days of culture) as compared with cells cul-
tured with neurons only (7 days of culture). That
observation suggested an earlier formation of
model BBB in the three-cell type system. If this
conclusion is correct, BCECs cultured alone or with
neurons and/or astrocytes should show different
ability to delay the paracellular sucrose passage
from the donor to the acceptor compartment in the
transwell modified system. In the present study we
indeed report that both astrocytes and neurons are
independently able to reduce the paracellular pas-
sage of sucrose. The effects of the two cell types are
additive: when BCECs are cocultured with both
astrocytes and neurons, the paracellular flux is
reduced to one third. However, the synergic effect is
visible only after 5 days of coculture: after three
days, indeed, any combination of brain cells added
to BCECs induce a similar reduction of the sucrose
passage. Interestingly, if we compare histograms of
figures 2 and 3, two conclusions could be drawn: i)
on average, while the percent of sucrose that cross-
es the BCEC layer after, for example, 120 minutes
is the same at 3 and 5 days of culture, the percent of
crossing sucrose is significantly (p<0.01) lower
after 5 days of coculture in all the coculture condi-
tions; ii) this effect is more evident for cocultures
containing both astrocytes and neurons. These
observations suggest that either the quality or/and
the intensity of the effects of astrocytes and neurons
on BCECs depend on how long the cells are cul-
tured together.
We also found that rabbit anti-human occludin
antibodies directed against an internal region of
human occludin (aminoacids 132-411), recognized
two different proteins, only one of which (p60) had
been expected. The second protein (p48) was never
described before at our knowledge. This protein
increases during development even more than p60
and, more interestingly, is enriched in BCECs cul-
tured with both astrocytes and neurons for 5 days,
that is in those conditions in which the BCEC layer
shows maximal effieciency as a barrier to sucrose
passage. Although it couldn't be  excluded that it
derives from occludin degradation, its abundance
together with the fact that the concentration of p48
changes significantly during development (Fig. 4)
and in different culture conditions (Fig. 5), in rela-
tion with establishment of a functional barrier, sug-
gests that it has a role to play in this latter event.
From this point of view, it has to be underlined that
p48 concentration correlates with formation of a
barrier much better than that of p60 itself, the con-
centration of which doesn't show significant differ-
ences neither during development nor in BCECs
cultured in different conditions. 
A further comment concerns the fact that, in our
culture system, both neurons and astrocytes exert an
effect on BCECs in the absence of cell-cell con-
tacts. This observation suggest that soluble factors
are involved. Experiments are now in progress to
clarify the molecular mechanisms underlying the
reciprocal effects of the three brain cell types.
In conclusion, we describe a novel three-cell
type system that could represent a powerful system
for studying the molecular mechanisms responsible
for BBB formation and maintenance as well as
BBB damage in neurodegenerative diseases such as
multiple sclerosis. This system could be also quite
useful for investigating the ability of a variety of
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prodrugs to cross BBB and to gain a functional
structure on the trans side of the barrier.
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